Your browser doesn't support javascript.
loading
Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study.
Bart, Stephan; Cannon, Kevin; Herrington, Darrell; Mills, Richard; Forleo-Neto, Eduardo; Lindert, Kelly; Abdul Mateen, Ahmed.
Affiliation
  • Bart S; a Optimal Research LLC , Rockville , MD , USA.
  • Cannon K; b PMG Research of Wilmington , Wilmington , NC , USA.
  • Herrington D; c Benchmark Research , San Angelo , TX , USA.
  • Mills R; d PMG Research of Charleston , Mt. Pleasant , SC , USA.
  • Forleo-Neto E; e Novartis Vaccines and Diagnostics Inc. , Cambridge , MA , USA.
  • Lindert K; e Novartis Vaccines and Diagnostics Inc. , Cambridge , MA , USA.
  • Abdul Mateen A; f Novartis Pharmaceuticals Canada Inc. , Dorval , Quebec , Canada.
Hum Vaccin Immunother ; 12(9): 2278-88, 2016 09.
Article in En | MEDLINE | ID: mdl-27322354
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Influenza Vaccines Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Hum Vaccin Immunother Year: 2016 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Influenza Vaccines Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Hum Vaccin Immunother Year: 2016 Type: Article Affiliation country: United States